We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo






  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 42

What did you say? $31 million awarded for infringement of hearing aid patent

  • McDermott Will & Emery
  • -
  • European Union
  • -
  • November 29 2012

In a case involving the alleged infringement of two patents related to hearing aids, one of which was found under judgment as a matter of law (JMOL) to not be infringed

Controlling and processing data in EU clinical trials

  • McDermott Will & Emery
  • -
  • European Union
  • -
  • November 22 2010

The legal regime for the conduct of clinical trials of medicinal products for human use in the European Union is set out in Directive 200120EC (the Clinical Trials Directive

EMEA and FDA focus on clinical research safety and enforcement

  • McDermott Will & Emery
  • -
  • European Union, USA
  • -
  • August 20 2009

Recent policy changes emphasize the need for sponsoring organizations to be even more vigilant in establishing, updating and monitoring their systems for compliance with clinical research requirements, whether conducted domestically or in a foreign locale

Advocate General opinion on the interpretation of “first marketing authorisation” for Supplementary Protection Certificates

  • McDermott Will & Emery
  • -
  • European Union
  • -
  • June 7 2012

Advocate General Trstenjak (the AG) has rendered an opinion in a preliminary reference relating to Neurim Pharmaceuticals Ltd 1991 C-13011 that it should be possible to grant a Supplementary Protection Certificate (SPC) for a second medicinal product that comprises the same active ingredient as a medicinal product covered by a prior marketing authorisation (MA), if the scope of the basic patent protecting the second medicinal product does not extend to the earlier medicinal product

EU Japan agreement on information exchange concerning medicines

  • McDermott Will & Emery
  • -
  • European Union, Japan
  • -
  • February 9 2007

After lengthy discussions, the European Union and Japan have reached an agreement on the exchange of confidential information about the authorisation and safety of medicines

Commission authorises reform of Belgian tax

  • McDermott Will & Emery
  • -
  • Belgium, European Union
  • -
  • February 1 2008

In Belgium pharmaceutical companies contribute to the financing of the health system through a tax calculated on the basis of sales of reimbursed medicines

High Court of England and Wales has jurisdiction to try pan-European declaration of non-infringement action

  • McDermott Will & Emery
  • -
  • European Union, United Kingdom
  • -
  • January 9 2013

In Actavis Group HF v Eli Lilly and Company 2012 EWHC 3316 (Pat) the High Court of England and Wales has held that, in cases where there is no challenge

Repackaging and parallel import of pharmaceutical products

  • McDermott Will & Emery
  • -
  • European Union
  • -
  • May 22 2007

On 27 April 2007, the European Court of Justice (the “ECJ”) handed down yet another decision in the case of Boehringer Ingelheim & others v Swingward Ltd and Dowelhurst Ltd, Case C-34804 (“Boehringer II”

Pharmaceutical sector under European Commission scanner

  • McDermott Will & Emery
  • -
  • European Union
  • -
  • February 28 2008

The European Commission has begun an investigation into the European pharmaceutical industry

Celltech: what’s in a name?

  • McDermott Will & Emery
  • -
  • European Union
  • -
  • May 22 2007

Celltech had filed an application with the Office of Harmonization for the Internal Market (“OHIM”) for registration of the word mark “Celltech” (combination of two terms ‘cell’ and ‘technology’) as a Community Trade Mark for goods and services in classes 5,10 and 42: ‘pharmaceutical, veterinary and sanitary preparations, compounds and substances’, ‘surgical, medical, dental and veterinary apparatus and instruments’ and ‘R&D services, consultancy services’

Current Search

Suggested Facets

Author

Jurisdiction

Workarea

© Copyright 2006-2013 Globe Business Publishing Ltd | Cookies | Disclaimer | Privacy policy